|
|
6705 Odyssey Drive Huntsville, AL 35806 USA phone:(866) 533-2932 fax:(256) 533-1474
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.applied-genomics.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Targeted genomics-based diagnostic and therapeutic antibodies for the treatment of cancer. |
 |
| Management |
| Rob Seitz, Chief Executive Officer and co-founder; Doug Ross, MD, PhD, Chief Scientific Officer and co-founder; Jessica Smith, PhD, Vice-President of Business Development; Doug Ross, MD, PhD; Rob Seitz; Jim Hudson; Roy Nichols; Lonnie McMillian |
| |
|
|
| |
|
| Keywords |
| genomics-based, antibody, cancer, Prognosis, gene expression |
|
|
|
| Description |
|
Applied Genomics, Inc. develops targeted genomics-based diagnostic and therapeutic antibodies for the treatment of cancer. |
 |
| Products / Services |
AGI is developing a novel set of tools and the expertise for the detection and classification of human cancer. The products include: Diagnostic panels of antibodies useful for identifying clinically relevant subcategories of tumors; ER+ Stage I Prognosis (Breast Prognostic Panel); Lung NSCLC Stage I/II Prognosis (Lung Prognostic Panel) ; Therapeutic drug development candidates.
|
 |
 |
|
|
|
|
|
|